< Back to latest news & events

Event

CTA Demo Day

October 2024

Event date: 24th October 2024

HGF is proud to be speaking at the Cancer Tech Accelerator Demo Day 2024.

The Cancer Tech Accelerator Day 2024 will be held at HGF Limited, Leeds on Thursday 24th October. There will be groundbreaking demos and pitches, the latest advancements in research that are shaping the future of cancer care. This event will provide the opportunity to enhance your knowledge in the MedTech and cancer research fields. There will also be networking opportunities.

HGF Partner and Head of Chemistry Andrew Wells is chairing a panel on IP Considerations of Spinout Companies. Daniel Woollaston, Alexandra Wood, Sofie McPherson, Punita Shah, Kieran Killough and David Hufton will also be attending.

Click the button below to find out more.

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

INTA 2025 Annual Meeting Live

The HGF European team will be attending the INTA Annual Meeting Live, which will take place on 17th-21st May in San Diego, US. The conference will connect some of the …

Read article

HGF wins big at the Managing IP EMEA Awards Ceremony 2025

The Annual Managing IP Awards: EMEA Awards 2025 were announced last night, and HGF are proud to have won 7 awards. The Managing IP Awards are highly recognised and respected …

Read article

Plant Patent Infringement in the US Relies on Evidence of Asexual Reproduction

A recent case in the US District Court for the Northern District of Texas (Dallas Division) once again highlights how important the initial pleadings and evidence in patent infringement cases …

Read article

Exam Success at HGF!

HGF is pleased to announce that several of our attorneys have passed their UK Advanced Patent exams! In no specific order, we would like to say well done and a …

Read article

IP Ingredients: How food companies are using IP to stay ahead of the GLP-1 curve

The impact of GLP-1 on the food and beverage sector GLP-1 agonists, best-known under the brand names Ozempic® and Wegovy®, are medicines used to treat type 2 diabetes and obesity. …

Read article

European Innovation Remains Strong: The EPO Patent Index 2024

The Patent Index 2024, recently published by the European Patent Office (EPO), provides a rich dataset from which key patent trends can be identified. The data shows that demand for …

Read article